BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 6054996)

  • 1. Inhibition of serotonin synthesis by para-chlorophenylalanine in patients with the carcinoid syndrome.
    Engelman K; Lovenberg W; Sjoerdsma A
    N Engl J Med; 1967 Nov; 277(21):1103-8. PubMed ID: 6054996
    [No Abstract]   [Full Text] [Related]  

  • 2. Serotonin now: clinical implications of inhibiting its synthesis with para-chlorophenylalanine.
    Ann Intern Med; 1970 Oct; 73(4):607-30. PubMed ID: 4319081
    [No Abstract]   [Full Text] [Related]  

  • 3. [Urinary 5-hydroxyindoles in carcinoid].
    Hosoda S; Nakamura W; Wakita T
    Gan No Rinsho; 1970 Sep; 16(9):954-5. PubMed ID: 5528967
    [No Abstract]   [Full Text] [Related]  

  • 4. Study of a possible physiologic interaction between ceruloplasmin and serotonin.
    Warner RR; Sternlieb I
    J Lab Clin Med; 1966 Jun; 67(6):934-6. PubMed ID: 5916141
    [No Abstract]   [Full Text] [Related]  

  • 5. Inhibition of phenylalanine hydroxylation during treatment of carcinoid syndrome with p-chlorophenylalanine.
    Szeinberg A; Shani M; Crispin M; Hirshorn N; Cohen BE; Sheba C
    Isr J Med Sci; 1970; 6(4):475-8. PubMed ID: 5472331
    [No Abstract]   [Full Text] [Related]  

  • 6. The carcinoid syndrome--a role for hemodialysis.
    Creagan ET; Tyce GM; Moertel CG
    Cancer Treat Rep; 1977; 61(1):107-8. PubMed ID: 861959
    [No Abstract]   [Full Text] [Related]  

  • 7. [Current views on carcinoid and the carcinoid syndrome].
    Ryss ES
    Klin Med (Mosk); 1971 Jan; 49(1):13-9. PubMed ID: 4396993
    [No Abstract]   [Full Text] [Related]  

  • 8. The carcinoid syndrome: chronic treatment with para-chlorophenylalanine.
    Satterlee WG; Serpick A; Bianchine JR
    Ann Intern Med; 1970 Jun; 72(6):919-21. PubMed ID: 5448751
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical aspects of indolealkylamine metabolism. Introductory remarks.
    Sjoerdsma A
    Adv Pharmacol (1962); 1968; 6(Pt B):123-5. PubMed ID: 5688650
    [No Abstract]   [Full Text] [Related]  

  • 10. Glucose metabolism and insulin secretion in the carcinoid syndrome.
    Feldman JM; Marecek RL; Quickel KE; Lebovitz HE
    J Clin Endocrinol Metab; 1972 Aug; 35(2):307-11. PubMed ID: 4262845
    [No Abstract]   [Full Text] [Related]  

  • 11. Plasma amino acids in patients with the carcinoid syndrome.
    Feldman JM; Plonk JW; Admiraal J; Sidbury JB
    Cancer; 1976 Nov; 38(5):2127-31. PubMed ID: 136295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Laboratory findings in the carcinoid syndrome].
    Kähler HJ
    Dtsch Med Wochenschr; 1968 May; 93(19):959-61. PubMed ID: 5300909
    [No Abstract]   [Full Text] [Related]  

  • 13. [Carcinoid and carcinoid syndrome].
    Vrubel F; Martínek K
    Cesk Gastroenterol Vyz; 1970 Oct; 24(7):286-90. PubMed ID: 5480235
    [No Abstract]   [Full Text] [Related]  

  • 14. Carcinoid tumors: effect on thyroid function.
    Bivens CH; Marecek RL; Feldman JM
    Am J Med Sci; 1973 Dec; 266(6):427-36. PubMed ID: 4129861
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of somatostatin infusion in four patients with malignant carcinoid syndrome.
    Quatrini M; Basilisco G; Conte D; Bozzani A; Bardella MT; Bianchi PA
    Am J Gastroenterol; 1983 Mar; 78(3):149-51. PubMed ID: 6187212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serotonin metabolism in patients with carcinoid tumors: incidence of 5-hydroxytryptophan-secreting tumors.
    Feldman JM
    Gastroenterology; 1978 Dec; 75(6):1109-14. PubMed ID: 309417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinguishing features of idiopathic flushing and carcinoid syndrome.
    Aldrich LB; Moattari AR; Vinik AI
    Arch Intern Med; 1988 Dec; 148(12):2614-8. PubMed ID: 2461688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Bronchial carcinoid and carcinoid syndrome].
    Biriukov IuV; Bassalyk LS; Kulikov LS; Men'shikov VV; Efimov BI
    Sov Med; 1970 Dec; 33(12):39-43. PubMed ID: 5516942
    [No Abstract]   [Full Text] [Related]  

  • 19. [Ileal carcinoid tumors. Predominant lesions of the left endocardium].
    Warter J; Batzenschlager A; Schirardin H; Grappe JM; Berthier G; Monath C
    Ann Med Interne (Paris); 1971 Oct; 122(10):967-74. PubMed ID: 5150731
    [No Abstract]   [Full Text] [Related]  

  • 20. Biochemical assessment of niacin deficiency among carcinoid cancer patients.
    Shah GM; Shah RG; Veillette H; Kirkland JB; Pasieka JL; Warner RR
    Am J Gastroenterol; 2005 Oct; 100(10):2307-14. PubMed ID: 16181385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.